Keywords: teva, bids, billion, barr, whose, shares, leapt

Teva bids $7.46 billion for Barr, whose shares leapt to two-year high on rumors

Article | 28 July 2008

Print This

Global generics number one Teva Pharmaceutical Industries announced mid-morning on July 18 that it has entered into a definitive agreement to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in